PAD 0115 (Flavoxate 100 mg)

Pill imprint PAD 0115 has been identified as Flavoxate hydrochloride 100 mg.

Flavoxate is used in the treatment of dysuria; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Flavoxate 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Flavoxate hydrochloride

Imprint:

PAD 0115

Strength:

100 mg

Color:

White

Size:

11.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Urinary antispasmodics

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Paddock Laboratories, Inc.

National Drug Code (NDC):

00574-0115

Inactive Ingredients:

silicon dioxide
methacrylic acid - ethyl acrylate copolymer (1:1) type a
hypromelloses
lactose monohydrate
magnesium stearate
methyl methacrylate
microcrystalline cellulose
sodium starch glycolate type A potato
hypromellose 2910 (6 mPa.s)
polyethylene glycol

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.